Enovis (ENOV) Equity Income (2022)
Enovis (ENOV) reported Equity Income of $30.3 million for Q4 2022, up 148.0% on a QoQ basis from -$63.1 million in Q3 2022.
Enovis (ENOV) has 1 years of Equity Income data on file, last reported at $30.3 million in Q4 2022.
- Quarterly Equity Income changed N/A year-over-year to $30.3 million in Q4 2022, while the trailing twelve-month figure through Dec 2023 was $30.3 million (down 70.5% YoY) and the FY2022 annual result came in at $102.7 million, changed N/A from the prior year.
- Equity Income climbed to $30.3 million in Q4 2022 per ENOV's latest filing, from -$63.1 million in the prior quarter.
- Across five years, Equity Income topped out at $135.5 million in Q3 2022 and bottomed at -$63.1 million in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Enovis | 1.25 Bn | 1.22 Bn | 365.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 30.30 Mn |
| Sep 30, 2022 | -63.13 Mn |
| Jul 1, 2022 | 135.54 Mn |